|
| Expert consensus on clinical application of “Qinggan Yin” series pharmaceutics |
| Hits 2473 Download times 1592 Received:October 10, 2020 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2020.11.01 |
| Key Words
Qinggan Yin;clinical application;expert consensus |
| Author Name | Affiliation | | REN Ming | Baokang Hospital Affiliated to Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | FU Kun | Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China | | ZHOU Shengyuan | Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China | | SUN Xiao | Baokang Hospital Affiliated to Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China |
|
| Abstract
|
| In order to reduce the risk of superposition of influenza and COVID-19 in autumn and winter,and reduce the pressure and cost of epidemic prevention and control,Tianjin Health Committee and Tianjin Society of Integrated Chinese and Western Medicine organized an expert group to jointly formulate Expert Consensus on Clinical Application of "Qinggan Yin" Series Pharmaceutics,providing professional guidance for the prevention and treatment of respiratory diseases. |
|
